NCT06632522尚未招募2 期
Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients With VP4.
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 46
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
Clinical study of radiotherapy combined with Camrelizumab and Apatinib in the treatment of liver cancer patients with VP4.
详细描述
This study is a single-arm, open, prospective and multi-center clinical study, aiming at observing and evaluating the efficacy and safety of radiotherapy combined with Camrelizumab and apatinib in the treatment of patients with VP4 liver cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
radiotherapy combined with Camrelizumab and Apatinib
Experimental
radiotherapy combined with Camrelizumab and Apatinib in the treatment of liver cancer patients with VP4
干预措施: radiotherapy combined with Camrelizumab and Apatinib (Drug)
结局指标
主要结局
Overall survival
时间窗: up to 3 years
The time from the beginning of treatment to the progression of the disease or death from any cause.
次要结局
- Progression-free survival(up to 3 years)
- Objective response rate(up to 3 years)
- Disease control rate(up to 3 years)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
3 期
Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal CarcinomaNasopharyngeal CarcinomaNCT04944914Sun Yat-sen University188
尚未招募
2 期
Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical CancerCervical CancerNCT06149767Fujian Cancer Hospital26
招募中
2 期
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical CancerLocally Advanced Cervical CancerNCT04884906Tianjin Medical University Cancer Institute and Hospital40
Unknown
不适用
Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive TumorsImmunotherapySBRTBulky TumorNCT04587817Peking University First Hospital60
尚未招募
2 期
Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.Advanced Esophageal Squamous Carcinoma With OligometastasesNCT06143722West China Hospital63